Laura Baker, PhD from the Wake Forest School of Medicine, Winston-Salem, NC talks about the interventions in the U.S. POINTER study at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK. One of the interventions involves more frequent monitoring of medical co-morbidities that increase the risk of cognitive decline. This type of intervention engages the patient to take responsibility of their own health. Vascular disease and metabolic disease, both of which have a high incidence and prevalence in the USA require close monitoring as both have a significant impact on cognitive health. Dr Baker talks about the critical use of feedback in this trial. To engage patients to look after and monitor their own health, she explains how introduction of electronic tools such as apps will be introduced so that patients can be aware of their health numbers. The individual then has the power to change these numbers themselves.